SCHEMBL25530880

SCHEMBL25530880

COC(=O)c1cccc(CN2C(=O)c3ccc(-c4ccnc(Cl)c4)cc3N(C)C(=O)[C@H]2C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.48
ROCK2 O75116 1/20 0.48
TNIK Q9UKE5 1/20 0.42
IDO1 P14902 1/20 0.41
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CD74 P04233 1/20 0.40
MIF P14174 1/20 0.40
CASP7 P55210 1/20 0.40
MAPT P10636 6/20 0.39
THRB P10828 1/20 0.39
TGM2 P21980 1/20 0.38
MAPK10 P53779 1/20 0.38
TRPA1 O75762 1/20 0.38
ABHD6 Q9BV23 1/20 0.37
CYP3A4 P08684 1/20 0.37
PRKACA P17612 1/20 0.37
YTHDC1 Q96MU7 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25529500 0.90 ROCK2 (0.59) ROCK1ROCK2TNIKIDO1GAA
SCHEMBL25530881 0.86 ROCK2 (0.48) ROCK1ROCK2TNIKIDO1GAA
SCHEMBL25529498 0.82 MAPT (0.48) ROCK1ROCK2TNIKIDO1GAA
SCHEMBL25530887 0.81 KMT2A (0.39) ROCK1ROCK2IDO1KMT2A
SCHEMBL25530633 0.81 ROCK2 (0.45) ROCK1ROCK2TNIKIDO1GAA
SCHEMBL25529501 0.80 ROCK1 (0.47) ROCK1ROCK2IDO1KMT2A
SCHEMBL25528328 0.79 BRD4 (0.43) ROCK1ROCK2CYP3A4
SCHEMBL25528181 0.76 ROCK2 (0.59) ROCK1ROCK2TNIKCYP3A4PRKACA
SCHEMBL25528180 0.76 ROCK2 (0.59) ROCK1ROCK2TNIKCYP3A4PRKACA
SCHEMBL25528176 0.76 ROCK2 (0.57) ROCK1ROCK2TNIKCYP3A4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed